Global Flow Cytometry in Oncology and Immunology Supply, Demand and Key Producers, 2023-2029

Description

The global Flow Cytometry in Oncology and Immunology market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

The global increase in HIV diagnoses is a significant market factor for flow cytometry, and this is because the flow cytometry technique is specifically used for HIV diagnosis. In flow cytometry, light scattering is utilized to identify cells. These cells receive particular markers known as CDs depending on the type of scattering (clusters of differentiation). The main market players are concentrating on creating new products, which is anticipated to propel market growth over the forecast year.

Flow cytometry is a powerful technology that is widely used in both oncology and immunology research. It is a technique used to analyze the physical and chemical properties of cells in a heterogeneous population, by labeling and detecting specific molecules on the surface of cells. The resulting data can provide information about the number, size, and complexity of cells in a sample, as well as their phenotype and function.

In oncology, flow cytometry is often used to analyze cancer cells and to monitor the progression of the disease. For example, flow cytometry can be used to identify and quantify cancer stem cells, which are thought to be responsible for tumor initiation and recurrence. It can also be used to measure the expression of tumor-associated antigens, which are molecules expressed by cancer cells that can be targeted by immunotherapy.

Overall, flow cytometry is a versatile tool that has many applications in oncology and immunology research. It can provide valuable information about the biology of cells and their interactions with other cells and molecules, and can help researchers to develop new diagnostic and therapeutic approaches for cancer and other diseases
This report studies the global Flow Cytometry in Oncology and Immunology demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Flow Cytometry in Oncology and Immunology, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Flow Cytometry in Oncology and Immunology that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Flow Cytometry in Oncology and Immunology total market, 2018-2029, (USD Million)
Global Flow Cytometry in Oncology and Immunology total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Flow Cytometry in Oncology and Immunology total market, key domestic companies and share, (USD Million)
Global Flow Cytometry in Oncology and Immunology revenue by player and market share 2018-2023, (USD Million)
Global Flow Cytometry in Oncology and Immunology total market by Type, CAGR, 2018-2029, (USD Million)
Global Flow Cytometry in Oncology and Immunology total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Flow Cytometry in Oncology and Immunology market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Agilent, ABYNTEK BIOPHARMA, Bio-Rad Laboratories, Cell Signaling Technology, Cytek Biosciences, Danaher Corporation,, DiaSorin S.p.A (Luminex Corporation),, Enzi Biochem Inc and Laboratory Corporation of America Holdings,, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Flow Cytometry in Oncology and Immunology market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Flow Cytometry in Oncology and Immunology Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Flow Cytometry in Oncology and Immunology Market, Segmentation by Type
    Products
    Services

Global Flow Cytometry in Oncology and Immunology Market, Segmentation by Application
    Immunology
    Oncology
    Solid Tumor

Companies Profiled:
    Agilent
    ABYNTEK BIOPHARMA
    Bio-Rad Laboratories
    Cell Signaling Technology
    Cytek Biosciences
    Danaher Corporation,
    DiaSorin S.p.A (Luminex Corporation),
    Enzi Biochem Inc
    Laboratory Corporation of America Holdings,
    Merck KGaA
    Miltenyi Biotec
    NeoGenomics Laboratories
    OPKO Health
    Sony Group Corporation
    Thermo Fisher Scientific Inc.

Key Questions Answered
1. How big is the global Flow Cytometry in Oncology and Immunology market?
2. What is the demand of the global Flow Cytometry in Oncology and Immunology market?
3. What is the year over year growth of the global Flow Cytometry in Oncology and Immunology market?
4. What is the total value of the global Flow Cytometry in Oncology and Immunology market?
5. Who are the major players in the global Flow Cytometry in Oncology and Immunology market?
6. What are the growth factors driving the market demand?

Table of Contents

1 Supply Summary
    1.1 Flow Cytometry in Oncology and Immunology Introduction
    1.2 World Flow Cytometry in Oncology and Immunology Market Size & Forecast (2018 & 2022 & 2029)
    1.3 World Flow Cytometry in Oncology and Immunology Total Market by Region (by Headquarter Location)
        1.3.1 World Flow Cytometry in Oncology and Immunology Market Size by Region (2018-2029), (by Headquarter Location)
        1.3.2 United States Flow Cytometry in Oncology and Immunology Market Size (2018-2029)
        1.3.3 China Flow Cytometry in Oncology and Immunology Market Size (2018-2029)
        1.3.4 Europe Flow Cytometry in Oncology and Immunology Market Size (2018-2029)
        1.3.5 Japan Flow Cytometry in Oncology and Immunology Market Size (2018-2029)
        1.3.6 South Korea Flow Cytometry in Oncology and Immunology Market Size (2018-2029)
        1.3.7 ASEAN Flow Cytometry in Oncology and Immunology Market Size (2018-2029)
        1.3.8 India Flow Cytometry in Oncology and Immunology Market Size (2018-2029)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Flow Cytometry in Oncology and Immunology Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Flow Cytometry in Oncology and Immunology Major Market Trends
    1.5 Influence of COVID-19 and Russia-Ukraine War
        1.5.1 Influence of COVID-19
        1.5.2 Influence of Russia-Ukraine War

2 Demand Summary
    2.1 World Flow Cytometry in Oncology and Immunology Consumption Value (2018-2029)
    2.2 World Flow Cytometry in Oncology and Immunology Consumption Value by Region
        2.2.1 World Flow Cytometry in Oncology and Immunology Consumption Value by Region (2018-2023)
        2.2.2 World Flow Cytometry in Oncology and Immunology Consumption Value Forecast by Region (2024-2029)
    2.3 United States Flow Cytometry in Oncology and Immunology Consumption Value (2018-2029)
    2.4 China Flow Cytometry in Oncology and Immunology Consumption Value (2018-2029)
    2.5 Europe Flow Cytometry in Oncology and Immunology Consumption Value (2018-2029)
    2.6 Japan Flow Cytometry in Oncology and Immunology Consumption Value (2018-2029)
    2.7 South Korea Flow Cytometry in Oncology and Immunology Consumption Value (2018-2029)
    2.8 ASEAN Flow Cytometry in Oncology and Immunology Consumption Value (2018-2029)
    2.9 India Flow Cytometry in Oncology and Immunology Consumption Value (2018-2029)

3 World Flow Cytometry in Oncology and Immunology Companies Competitive Analysis
    3.1 World Flow Cytometry in Oncology and Immunology Revenue by Player (2018-2023)
    3.2 Industry Rank and Concentration Rate (CR)
        3.2.1 Global Flow Cytometry in Oncology and Immunology Industry Rank of Major Players
        3.2.2 Global Concentration Ratios (CR4) for Flow Cytometry in Oncology and Immunology in 2022
        3.2.3 Global Concentration Ratios (CR8) for Flow Cytometry in Oncology and Immunology in 2022
    3.3 Flow Cytometry in Oncology and Immunology Company Evaluation Quadrant
    3.4 Flow Cytometry in Oncology and Immunology Market: Overall Company Footprint Analysis
        3.4.1 Flow Cytometry in Oncology and Immunology Market: Region Footprint
        3.4.2 Flow Cytometry in Oncology and Immunology Market: Company Product Type Footprint
        3.4.3 Flow Cytometry in Oncology and Immunology Market: Company Product Application Footprint
    3.5 Competitive Environment
        3.5.1 Historical Structure of the Industry
        3.5.2 Barriers of Market Entry
        3.5.3 Factors of Competition
    3.6 Mergers, Acquisitions Activity

4 United States VS China VS Rest of the World (by Headquarter Location)
    4.1 United States VS China: Flow Cytometry in Oncology and Immunology Revenue Comparison (by Headquarter Location)
        4.1.1 United States VS China: Flow Cytometry in Oncology and Immunology Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
        4.1.2 United States VS China: Flow Cytometry in Oncology and Immunology Revenue Market Share Comparison (2018 & 2022 & 2029)
    4.2 United States Based Companies VS China Based Companies: Flow Cytometry in Oncology and Immunology Consumption Value Comparison
        4.2.1 United States VS China: Flow Cytometry in Oncology and Immunology Consumption Value Comparison (2018 & 2022 & 2029)
        4.2.2 United States VS China: Flow Cytometry in Oncology and Immunology Consumption Value Market Share Comparison (2018 & 2022 & 2029)
    4.3 United States Based Flow Cytometry in Oncology and Immunology Companies and Market Share, 2018-2023
        4.3.1 United States Based Flow Cytometry in Oncology and Immunology Companies, Headquarters (States, Country)
        4.3.2 United States Based Companies Flow Cytometry in Oncology and Immunology Revenue, (2018-2023)
    4.4 China Based Companies Flow Cytometry in Oncology and Immunology Revenue and Market Share, 2018-2023
        4.4.1 China Based Flow Cytometry in Oncology and Immunology Companies, Company Headquarters (Province, Country)
        4.4.2 China Based Companies Flow Cytometry in Oncology and Immunology Revenue, (2018-2023)
    4.5 Rest of World Based Flow Cytometry in Oncology and Immunology Companies and Market Share, 2018-2023
        4.5.1 Rest of World Based Flow Cytometry in Oncology and Immunology Companies, Headquarters (States, Country)
        4.5.2 Rest of World Based Companies Flow Cytometry in Oncology and Immunology Revenue, (2018-2023)

5 Market Analysis by Type
    5.1 World Flow Cytometry in Oncology and Immunology Market Size Overview by Type: 2018 VS 2022 VS 2029
    5.2 Segment Introduction by Type
        5.2.1 Products
        5.2.2 Services
    5.3 Market Segment by Type
        5.3.1 World Flow Cytometry in Oncology and Immunology Market Size by Type (2018-2023)
        5.3.2 World Flow Cytometry in Oncology and Immunology Market Size by Type (2024-2029)
        5.3.3 World Flow Cytometry in Oncology and Immunology Market Size Market Share by Type (2018-2029)

6 Market Analysis by Application
    6.1 World Flow Cytometry in Oncology and Immunology Market Size Overview by Application: 2018 VS 2022 VS 2029
    6.2 Segment Introduction by Application
        6.2.1 Immunology
        6.2.2 Oncology
        6.2.3 Solid Tumor
    6.3 Market Segment by Application
        6.3.1 World Flow Cytometry in Oncology and Immunology Market Size by Application (2018-2023)
        6.3.2 World Flow Cytometry in Oncology and Immunology Market Size by Application (2024-2029)
        6.3.3 World Flow Cytometry in Oncology and Immunology Market Size by Application (2018-2029)

7 Company Profiles
    7.1 Agilent
        7.1.1 Agilent Details
        7.1.2 Agilent Major Business
        7.1.3 Agilent Flow Cytometry in Oncology and Immunology Product and Services
        7.1.4 Agilent Flow Cytometry in Oncology and Immunology Revenue, Gross Margin and Market Share (2018-2023)
        7.1.5 Agilent Recent Developments/Updates
        7.1.6 Agilent Competitive Strengths & Weaknesses
    7.2 ABYNTEK BIOPHARMA
        7.2.1 ABYNTEK BIOPHARMA Details
        7.2.2 ABYNTEK BIOPHARMA Major Business
        7.2.3 ABYNTEK BIOPHARMA Flow Cytometry in Oncology and Immunology Product and Services
        7.2.4 ABYNTEK BIOPHARMA Flow Cytometry in Oncology and Immunology Revenue, Gross Margin and Market Share (2018-2023)
        7.2.5 ABYNTEK BIOPHARMA Recent Developments/Updates
        7.2.6 ABYNTEK BIOPHARMA Competitive Strengths & Weaknesses
    7.3 Bio-Rad Laboratories
        7.3.1 Bio-Rad Laboratories Details
        7.3.2 Bio-Rad Laboratories Major Business
        7.3.3 Bio-Rad Laboratories Flow Cytometry in Oncology and Immunology Product and Services
        7.3.4 Bio-Rad Laboratories Flow Cytometry in Oncology and Immunology Revenue, Gross Margin and Market Share (2018-2023)
        7.3.5 Bio-Rad Laboratories Recent Developments/Updates
        7.3.6 Bio-Rad Laboratories Competitive Strengths & Weaknesses
    7.4 Cell Signaling Technology
        7.4.1 Cell Signaling Technology Details
        7.4.2 Cell Signaling Technology Major Business
        7.4.3 Cell Signaling Technology Flow Cytometry in Oncology and Immunology Product and Services
        7.4.4 Cell Signaling Technology Flow Cytometry in Oncology and Immunology Revenue, Gross Margin and Market Share (2018-2023)
        7.4.5 Cell Signaling Technology Recent Developments/Updates
        7.4.6 Cell Signaling Technology Competitive Strengths & Weaknesses
    7.5 Cytek Biosciences
        7.5.1 Cytek Biosciences Details
        7.5.2 Cytek Biosciences Major Business
        7.5.3 Cytek Biosciences Flow Cytometry in Oncology and Immunology Product and Services
        7.5.4 Cytek Biosciences Flow Cytometry in Oncology and Immunology Revenue, Gross Margin and Market Share (2018-2023)
        7.5.5 Cytek Biosciences Recent Developments/Updates
        7.5.6 Cytek Biosciences Competitive Strengths & Weaknesses
    7.6 Danaher Corporation,
        7.6.1 Danaher Corporation, Details
        7.6.2 Danaher Corporation, Major Business
        7.6.3 Danaher Corporation, Flow Cytometry in Oncology and Immunology Product and Services
        7.6.4 Danaher Corporation, Flow Cytometry in Oncology and Immunology Revenue, Gross Margin and Market Share (2018-2023)
        7.6.5 Danaher Corporation, Recent Developments/Updates
        7.6.6 Danaher Corporation, Competitive Strengths & Weaknesses
    7.7 DiaSorin S.p.A (Luminex Corporation),
        7.7.1 DiaSorin S.p.A (Luminex Corporation), Details
        7.7.2 DiaSorin S.p.A (Luminex Corporation), Major Business
        7.7.3 DiaSorin S.p.A (Luminex Corporation), Flow Cytometry in Oncology and Immunology Product and Services
        7.7.4 DiaSorin S.p.A (Luminex Corporation), Flow Cytometry in Oncology and Immunology Revenue, Gross Margin and Market Share (2018-2023)
        7.7.5 DiaSorin S.p.A (Luminex Corporation), Recent Developments/Updates
        7.7.6 DiaSorin S.p.A (Luminex Corporation), Competitive Strengths & Weaknesses
    7.8 Enzi Biochem Inc
        7.8.1 Enzi Biochem Inc Details
        7.8.2 Enzi Biochem Inc Major Business
        7.8.3 Enzi Biochem Inc Flow Cytometry in Oncology and Immunology Product and Services
        7.8.4 Enzi Biochem Inc Flow Cytometry in Oncology and Immunology Revenue, Gross Margin and Market Share (2018-2023)
        7.8.5 Enzi Biochem Inc Recent Developments/Updates
        7.8.6 Enzi Biochem Inc Competitive Strengths & Weaknesses
    7.9 Laboratory Corporation of America Holdings,
        7.9.1 Laboratory Corporation of America Holdings, Details
        7.9.2 Laboratory Corporation of America Holdings, Major Business
        7.9.3 Laboratory Corporation of America Holdings, Flow Cytometry in Oncology and Immunology Product and Services
        7.9.4 Laboratory Corporation of America Holdings, Flow Cytometry in Oncology and Immunology Revenue, Gross Margin and Market Share (2018-2023)
        7.9.5 Laboratory Corporation of America Holdings, Recent Developments/Updates
        7.9.6 Laboratory Corporation of America Holdings, Competitive Strengths & Weaknesses
    7.10 Merck KGaA
        7.10.1 Merck KGaA Details
        7.10.2 Merck KGaA Major Business
        7.10.3 Merck KGaA Flow Cytometry in Oncology and Immunology Product and Services
        7.10.4 Merck KGaA Flow Cytometry in Oncology and Immunology Revenue, Gross Margin and Market Share (2018-2023)
        7.10.5 Merck KGaA Recent Developments/Updates
        7.10.6 Merck KGaA Competitive Strengths & Weaknesses
    7.11 Miltenyi Biotec
        7.11.1 Miltenyi Biotec Details
        7.11.2 Miltenyi Biotec Major Business
        7.11.3 Miltenyi Biotec Flow Cytometry in Oncology and Immunology Product and Services
        7.11.4 Miltenyi Biotec Flow Cytometry in Oncology and Immunology Revenue, Gross Margin and Market Share (2018-2023)
        7.11.5 Miltenyi Biotec Recent Developments/Updates
        7.11.6 Miltenyi Biotec Competitive Strengths & Weaknesses
    7.12 NeoGenomics Laboratories
        7.12.1 NeoGenomics Laboratories Details
        7.12.2 NeoGenomics Laboratories Major Business
        7.12.3 NeoGenomics Laboratories Flow Cytometry in Oncology and Immunology Product and Services
        7.12.4 NeoGenomics Laboratories Flow Cytometry in Oncology and Immunology Revenue, Gross Margin and Market Share (2018-2023)
        7.12.5 NeoGenomics Laboratories Recent Developments/Updates
        7.12.6 NeoGenomics Laboratories Competitive Strengths & Weaknesses
    7.13 OPKO Health
        7.13.1 OPKO Health Details
        7.13.2 OPKO Health Major Business
        7.13.3 OPKO Health Flow Cytometry in Oncology and Immunology Product and Services
        7.13.4 OPKO Health Flow Cytometry in Oncology and Immunology Revenue, Gross Margin and Market Share (2018-2023)
        7.13.5 OPKO Health Recent Developments/Updates
        7.13.6 OPKO Health Competitive Strengths & Weaknesses
    7.14 Sony Group Corporation
        7.14.1 Sony Group Corporation Details
        7.14.2 Sony Group Corporation Major Business
        7.14.3 Sony Group Corporation Flow Cytometry in Oncology and Immunology Product and Services
        7.14.4 Sony Group Corporation Flow Cytometry in Oncology and Immunology Revenue, Gross Margin and Market Share (2018-2023)
        7.14.5 Sony Group Corporation Recent Developments/Updates
        7.14.6 Sony Group Corporation Competitive Strengths & Weaknesses
    7.15 Thermo Fisher Scientific Inc.
        7.15.1 Thermo Fisher Scientific Inc. Details
        7.15.2 Thermo Fisher Scientific Inc. Major Business
        7.15.3 Thermo Fisher Scientific Inc. Flow Cytometry in Oncology and Immunology Product and Services
        7.15.4 Thermo Fisher Scientific Inc. Flow Cytometry in Oncology and Immunology Revenue, Gross Margin and Market Share (2018-2023)
        7.15.5 Thermo Fisher Scientific Inc. Recent Developments/Updates
        7.15.6 Thermo Fisher Scientific Inc. Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Flow Cytometry in Oncology and Immunology Industry Chain
    8.2 Flow Cytometry in Oncology and Immunology Upstream Analysis
    8.3 Flow Cytometry in Oncology and Immunology Midstream Analysis
    8.4 Flow Cytometry in Oncology and Immunology Downstream Analysis

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Flow Cytometry in Oncology and Immunology Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
    Table 2. World Flow Cytometry in Oncology and Immunology Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
    Table 3. World Flow Cytometry in Oncology and Immunology Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
    Table 4. World Flow Cytometry in Oncology and Immunology Revenue Market Share by Region (2018-2023), (by Headquarter Location)
    Table 5. World Flow Cytometry in Oncology and Immunology Revenue Market Share by Region (2024-2029), (by Headquarter Location)
    Table 6. Major Market Trends
    Table 7. World Flow Cytometry in Oncology and Immunology Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
    Table 8. World Flow Cytometry in Oncology and Immunology Consumption Value by Region (2018-2023) & (USD Million)
    Table 9. World Flow Cytometry in Oncology and Immunology Consumption Value Forecast by Region (2024-2029) & (USD Million)
    Table 10. World Flow Cytometry in Oncology and Immunology Revenue by Player (2018-2023) & (USD Million)
    Table 11. Revenue Market Share of Key Flow Cytometry in Oncology and Immunology Players in 2022
    Table 12. World Flow Cytometry in Oncology and Immunology Industry Rank of Major Player, Based on Revenue in 2022
    Table 13. Global Flow Cytometry in Oncology and Immunology Company Evaluation Quadrant
    Table 14. Head Office of Key Flow Cytometry in Oncology and Immunology Player
    Table 15. Flow Cytometry in Oncology and Immunology Market: Company Product Type Footprint
    Table 16. Flow Cytometry in Oncology and Immunology Market: Company Product Application Footprint
    Table 17. Flow Cytometry in Oncology and Immunology Mergers & Acquisitions Activity
    Table 18. United States VS China Flow Cytometry in Oncology and Immunology Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 19. United States VS China Flow Cytometry in Oncology and Immunology Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 20. United States Based Flow Cytometry in Oncology and Immunology Companies, Headquarters (States, Country)
    Table 21. United States Based Companies Flow Cytometry in Oncology and Immunology Revenue, (2018-2023) & (USD Million)
    Table 22. United States Based Companies Flow Cytometry in Oncology and Immunology Revenue Market Share (2018-2023)
    Table 23. China Based Flow Cytometry in Oncology and Immunology Companies, Headquarters (Province, Country)
    Table 24. China Based Companies Flow Cytometry in Oncology and Immunology Revenue, (2018-2023) & (USD Million)
    Table 25. China Based Companies Flow Cytometry in Oncology and Immunology Revenue Market Share (2018-2023)
    Table 26. Rest of World Based Flow Cytometry in Oncology and Immunology Companies, Headquarters (States, Country)
    Table 27. Rest of World Based Companies Flow Cytometry in Oncology and Immunology Revenue, (2018-2023) & (USD Million)
    Table 28. Rest of World Based Companies Flow Cytometry in Oncology and Immunology Revenue Market Share (2018-2023)
    Table 29. World Flow Cytometry in Oncology and Immunology Market Size by Type, (USD Million), 2018 & 2022 & 2029
    Table 30. World Flow Cytometry in Oncology and Immunology Market Size by Type (2018-2023) & (USD Million)
    Table 31. World Flow Cytometry in Oncology and Immunology Market Size by Type (2024-2029) & (USD Million)
    Table 32. World Flow Cytometry in Oncology and Immunology Market Size by Application, (USD Million), 2018 & 2022 & 2029
    Table 33. World Flow Cytometry in Oncology and Immunology Market Size by Application (2018-2023) & (USD Million)
    Table 34. World Flow Cytometry in Oncology and Immunology Market Size by Application (2024-2029) & (USD Million)
    Table 35. Agilent Basic Information, Area Served and Competitors
    Table 36. Agilent Major Business
    Table 37. Agilent Flow Cytometry in Oncology and Immunology Product and Services
    Table 38. Agilent Flow Cytometry in Oncology and Immunology Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 39. Agilent Recent Developments/Updates
    Table 40. Agilent Competitive Strengths & Weaknesses
    Table 41. ABYNTEK BIOPHARMA Basic Information, Area Served and Competitors
    Table 42. ABYNTEK BIOPHARMA Major Business
    Table 43. ABYNTEK BIOPHARMA Flow Cytometry in Oncology and Immunology Product and Services
    Table 44. ABYNTEK BIOPHARMA Flow Cytometry in Oncology and Immunology Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 45. ABYNTEK BIOPHARMA Recent Developments/Updates
    Table 46. ABYNTEK BIOPHARMA Competitive Strengths & Weaknesses
    Table 47. Bio-Rad Laboratories Basic Information, Area Served and Competitors
    Table 48. Bio-Rad Laboratories Major Business
    Table 49. Bio-Rad Laboratories Flow Cytometry in Oncology and Immunology Product and Services
    Table 50. Bio-Rad Laboratories Flow Cytometry in Oncology and Immunology Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 51. Bio-Rad Laboratories Recent Developments/Updates
    Table 52. Bio-Rad Laboratories Competitive Strengths & Weaknesses
    Table 53. Cell Signaling Technology Basic Information, Area Served and Competitors
    Table 54. Cell Signaling Technology Major Business
    Table 55. Cell Signaling Technology Flow Cytometry in Oncology and Immunology Product and Services
    Table 56. Cell Signaling Technology Flow Cytometry in Oncology and Immunology Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 57. Cell Signaling Technology Recent Developments/Updates
    Table 58. Cell Signaling Technology Competitive Strengths & Weaknesses
    Table 59. Cytek Biosciences Basic Information, Area Served and Competitors
    Table 60. Cytek Biosciences Major Business
    Table 61. Cytek Biosciences Flow Cytometry in Oncology and Immunology Product and Services
    Table 62. Cytek Biosciences Flow Cytometry in Oncology and Immunology Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 63. Cytek Biosciences Recent Developments/Updates
    Table 64. Cytek Biosciences Competitive Strengths & Weaknesses
    Table 65. Danaher Corporation, Basic Information, Area Served and Competitors
    Table 66. Danaher Corporation, Major Business
    Table 67. Danaher Corporation, Flow Cytometry in Oncology and Immunology Product and Services
    Table 68. Danaher Corporation, Flow Cytometry in Oncology and Immunology Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 69. Danaher Corporation, Recent Developments/Updates
    Table 70. Danaher Corporation, Competitive Strengths & Weaknesses
    Table 71. DiaSorin S.p.A (Luminex Corporation), Basic Information, Area Served and Competitors
    Table 72. DiaSorin S.p.A (Luminex Corporation), Major Business
    Table 73. DiaSorin S.p.A (Luminex Corporation), Flow Cytometry in Oncology and Immunology Product and Services
    Table 74. DiaSorin S.p.A (Luminex Corporation), Flow Cytometry in Oncology and Immunology Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 75. DiaSorin S.p.A (Luminex Corporation), Recent Developments/Updates
    Table 76. DiaSorin S.p.A (Luminex Corporation), Competitive Strengths & Weaknesses
    Table 77. Enzi Biochem Inc Basic Information, Area Served and Competitors
    Table 78. Enzi Biochem Inc Major Business
    Table 79. Enzi Biochem Inc Flow Cytometry in Oncology and Immunology Product and Services
    Table 80. Enzi Biochem Inc Flow Cytometry in Oncology and Immunology Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 81. Enzi Biochem Inc Recent Developments/Updates
    Table 82. Enzi Biochem Inc Competitive Strengths & Weaknesses
    Table 83. Laboratory Corporation of America Holdings, Basic Information, Area Served and Competitors
    Table 84. Laboratory Corporation of America Holdings, Major Business
    Table 85. Laboratory Corporation of America Holdings, Flow Cytometry in Oncology and Immunology Product and Services
    Table 86. Laboratory Corporation of America Holdings, Flow Cytometry in Oncology and Immunology Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 87. Laboratory Corporation of America Holdings, Recent Developments/Updates
    Table 88. Laboratory Corporation of America Holdings, Competitive Strengths & Weaknesses
    Table 89. Merck KGaA Basic Information, Area Served and Competitors
    Table 90. Merck KGaA Major Business
    Table 91. Merck KGaA Flow Cytometry in Oncology and Immunology Product and Services
    Table 92. Merck KGaA Flow Cytometry in Oncology and Immunology Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 93. Merck KGaA Recent Developments/Updates
    Table 94. Merck KGaA Competitive Strengths & Weaknesses
    Table 95. Miltenyi Biotec Basic Information, Area Served and Competitors
    Table 96. Miltenyi Biotec Major Business
    Table 97. Miltenyi Biotec Flow Cytometry in Oncology and Immunology Product and Services
    Table 98. Miltenyi Biotec Flow Cytometry in Oncology and Immunology Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 99. Miltenyi Biotec Recent Developments/Updates
    Table 100. Miltenyi Biotec Competitive Strengths & Weaknesses
    Table 101. NeoGenomics Laboratories Basic Information, Area Served and Competitors
    Table 102. NeoGenomics Laboratories Major Business
    Table 103. NeoGenomics Laboratories Flow Cytometry in Oncology and Immunology Product and Services
    Table 104. NeoGenomics Laboratories Flow Cytometry in Oncology and Immunology Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 105. NeoGenomics Laboratories Recent Developments/Updates
    Table 106. NeoGenomics Laboratories Competitive Strengths & Weaknesses
    Table 107. OPKO Health Basic Information, Area Served and Competitors
    Table 108. OPKO Health Major Business
    Table 109. OPKO Health Flow Cytometry in Oncology and Immunology Product and Services
    Table 110. OPKO Health Flow Cytometry in Oncology and Immunology Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 111. OPKO Health Recent Developments/Updates
    Table 112. OPKO Health Competitive Strengths & Weaknesses
    Table 113. Sony Group Corporation Basic Information, Area Served and Competitors
    Table 114. Sony Group Corporation Major Business
    Table 115. Sony Group Corporation Flow Cytometry in Oncology and Immunology Product and Services
    Table 116. Sony Group Corporation Flow Cytometry in Oncology and Immunology Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 117. Sony Group Corporation Recent Developments/Updates
    Table 118. Thermo Fisher Scientific Inc. Basic Information, Area Served and Competitors
    Table 119. Thermo Fisher Scientific Inc. Major Business
    Table 120. Thermo Fisher Scientific Inc. Flow Cytometry in Oncology and Immunology Product and Services
    Table 121. Thermo Fisher Scientific Inc. Flow Cytometry in Oncology and Immunology Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 122. Global Key Players of Flow Cytometry in Oncology and Immunology Upstream (Raw Materials)
    Table 123. Flow Cytometry in Oncology and Immunology Typical Customers
List of Figure
    Figure 1. Flow Cytometry in Oncology and Immunology Picture
    Figure 2. World Flow Cytometry in Oncology and Immunology Total Market Size: 2018 & 2022 & 2029, (USD Million)
    Figure 3. World Flow Cytometry in Oncology and Immunology Total Market Size (2018-2029) & (USD Million)
    Figure 4. World Flow Cytometry in Oncology and Immunology Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
    Figure 5. World Flow Cytometry in Oncology and Immunology Revenue Market Share by Region (2018-2029), (by Headquarter Location)
    Figure 6. United States Based Company Flow Cytometry in Oncology and Immunology Revenue (2018-2029) & (USD Million)
    Figure 7. China Based Company Flow Cytometry in Oncology and Immunology Revenue (2018-2029) & (USD Million)
    Figure 8. Europe Based Company Flow Cytometry in Oncology and Immunology Revenue (2018-2029) & (USD Million)
    Figure 9. Japan Based Company Flow Cytometry in Oncology and Immunology Revenue (2018-2029) & (USD Million)
    Figure 10. South Korea Based Company Flow Cytometry in Oncology and Immunology Revenue (2018-2029) & (USD Million)
    Figure 11. ASEAN Based Company Flow Cytometry in Oncology and Immunology Revenue (2018-2029) & (USD Million)
    Figure 12. India Based Company Flow Cytometry in Oncology and Immunology Revenue (2018-2029) & (USD Million)
    Figure 13. Flow Cytometry in Oncology and Immunology Market Drivers
    Figure 14. Factors Affecting Demand
    Figure 15. World Flow Cytometry in Oncology and Immunology Consumption Value (2018-2029) & (USD Million)
    Figure 16. World Flow Cytometry in Oncology and Immunology Consumption Value Market Share by Region (2018-2029)
    Figure 17. United States Flow Cytometry in Oncology and Immunology Consumption Value (2018-2029) & (USD Million)
    Figure 18. China Flow Cytometry in Oncology and Immunology Consumption Value (2018-2029) & (USD Million)
    Figure 19. Europe Flow Cytometry in Oncology and Immunology Consumption Value (2018-2029) & (USD Million)
    Figure 20. Japan Flow Cytometry in Oncology and Immunology Consumption Value (2018-2029) & (USD Million)
    Figure 21. South Korea Flow Cytometry in Oncology and Immunology Consumption Value (2018-2029) & (USD Million)
    Figure 22. ASEAN Flow Cytometry in Oncology and Immunology Consumption Value (2018-2029) & (USD Million)
    Figure 23. India Flow Cytometry in Oncology and Immunology Consumption Value (2018-2029) & (USD Million)
    Figure 24. Producer Shipments of Flow Cytometry in Oncology and Immunology by Player Revenue ($MM) and Market Share (%): 2022
    Figure 25. Global Four-firm Concentration Ratios (CR4) for Flow Cytometry in Oncology and Immunology Markets in 2022
    Figure 26. Global Four-firm Concentration Ratios (CR8) for Flow Cytometry in Oncology and Immunology Markets in 2022
    Figure 27. United States VS China: Flow Cytometry in Oncology and Immunology Revenue Market Share Comparison (2018 & 2022 & 2029)
    Figure 28. United States VS China: Flow Cytometry in Oncology and Immunology Consumption Value Market Share Comparison (2018 & 2022 & 2029)
    Figure 29. World Flow Cytometry in Oncology and Immunology Market Size by Type, (USD Million), 2018 & 2022 & 2029
    Figure 30. World Flow Cytometry in Oncology and Immunology Market Size Market Share by Type in 2022
    Figure 31. Products
    Figure 32. Services
    Figure 33. World Flow Cytometry in Oncology and Immunology Market Size Market Share by Type (2018-2029)
    Figure 34. World Flow Cytometry in Oncology and Immunology Market Size by Application, (USD Million), 2018 & 2022 & 2029
    Figure 35. World Flow Cytometry in Oncology and Immunology Market Size Market Share by Application in 2022
    Figure 36. Immunology
    Figure 37. Oncology
    Figure 38. Solid Tumor
    Figure 39. Flow Cytometry in Oncology and Immunology Industrial Chain
    Figure 40. Methodology
    Figure 41. Research Process and Data Source

Companies Mentioned

Agilent
ABYNTEK BIOPHARMA
Bio-Rad Laboratories
Cell Signaling Technology
Cytek Biosciences
Danaher Corporation,
DiaSorin S.p.A (Luminex Corporation),
Enzi Biochem Inc
Laboratory Corporation of America Holdings,
Merck KGaA
Miltenyi Biotec
NeoGenomics Laboratories
OPKO Health
Sony Group Corporation
Thermo Fisher Scientific Inc.